0
Red — act now
2
Amber — monitor
2
Green — opportunity
Amber alerts — monitor
Amber Evidence — ADA position · July 2026
Charcoal toothpaste category continues without ADA Seal recognition or safety consensus

The charcoal toothpaste category continues without ADA Seal recognition or a safety consensus. Ongoing consumer demand keeps reputational exposure live for any client product in this space.

Consumer search and social signals also inform velocity rating.

Monitor ADA position
Amber Regulatory — FDA OTC status · July 2026
Hydroxyapatite remains unapproved for anti-caries claims in the US

Hydroxyapatite remains unapproved for anti-caries claims in the US. Claims drafted for EU or Japan markets cannot be reused domestically without regulatory risk.

Consumer search and social signals also inform velocity rating.

Monitor FDA docket
Green signals — opportunities
Opportunity Commercial — PAP whitening · July 2026
PAP+ whitening adoption is broadening across DTC brands

PAP+ whitening adoption is broadening across DTC brands with no adverse safety signal identified to date.

Consumer search and social signals also inform velocity rating.

Opportunity Clinical — hydroxyapatite · July 2026
Active US trials are building the hydroxyapatite evidence base

Active US clinical trials on hydroxyapatite remineralization and dentin hypersensitivity are underway, building the evidence base needed for future claims.

Consumer search and social signals also inform velocity rating.

"In oral health, the evidence narrative is not just a regulatory requirement — it is the brand. Brands that build clinical credibility now are building the moat that protects them for a decade."

Schedule a consultation →